Fractyl Announces FDA Breakthrough Device Designation for Revita® DMR in Insulin-Treated Type 2 Diabetes
Fractyl Laboratories Inc., announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device ...
Read more
Tag: Fractyl
